{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:21:49Z","timestamp":1785450109776,"version":"3.56.0"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Metabolomics may help refine risk assessment and potentially guide HF management, but dedicated studies are few. This study aims at stratifying the long-term risk of death in a cohort of patients affected by HF due to dilated cardiomyopathy (DCM) using serum metabolomics <jats:italic>via<\/jats:italic> nuclear magnetic resonance (NMR) spectroscopy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A cohort of 106 patients with HF due to DCM, diagnosed and monitored between 1982 and 2011, were consecutively enrolled between 2010 and 2012, and a serum sample was collected from each participant. Each patient underwent half-yearly clinical assessments, and survival status at the last follow-up visit in 2019 was recorded. The NMR serum metabolomic profiles were retrospectively analyzed to evaluate the patient's risk of death. Overall, 26 patients died during the 8-years of the study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The metabolomic fingerprint at enrollment was powerful in discriminating patients who died (HR 5.71, <jats:italic>p<\/jats:italic> = 0.00002), even when adjusted for potential covariates. The outcome prediction of metabolomics surpassed that of N-terminal pro b-type natriuretic peptide (NT-proBNP) (HR 2.97, <jats:italic>p<\/jats:italic> = 0.005). Metabolomic fingerprinting was able to sub-stratify the risk of death in patients with both preserved\/mid-range and reduced ejection fraction [hazard ratio (HR) 3.46, <jats:italic>p<\/jats:italic> = 0.03; HR 6.01, <jats:italic>p<\/jats:italic> = 0.004, respectively]. Metabolomics and left ventricular ejection fraction (LVEF), combined in a score, proved to be synergistic in predicting survival (HR 8.09, <jats:italic>p<\/jats:italic> = 0.0000004).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Metabolomic analysis <jats:italic>via<\/jats:italic> NMR enables fast and reproducible characterization of the serum metabolic fingerprint associated with poor prognosis in the HF setting. Our data suggest the importance of integrating several risk parameters to early identify HF patients at high-risk of poor outcomes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.851905","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T04:33:49Z","timestamp":1649306029000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Metabolomics Fingerprint Predicts Risk of Death in Dilated Cardiomyopathy and Heart Failure"],"prefix":"10.3389","volume":"9","author":[{"given":"Alessia","family":"Vignoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Fornaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Tenori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Castelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Cecconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Olivotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Marchionni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brunetto","family":"Alterini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Luchinat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","article-title":"Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for the clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases","volume":"37","author":"Pinto","year":"2016","journal-title":"Eur Heart J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jacc.2012.05.005","article-title":"Where genome meets phenome: rationale for integrating genetic and protein biomarkers in the diagnosis and management of dilated cardiomyopathy and heart failure","volume":"60","author":"Piran","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.jacc.2004.11.066","article-title":"Clinical and genetic issues in familial dilated cardiomyopathy","volume":"45","author":"Burkett","year":"2005","journal-title":"J Am Coll Cardiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/ejhf.1461","article-title":"Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology","volume":"21","author":"Seferovi\u0107","year":"2019","journal-title":"Eur J Heart Fail."},{"key":"B5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11897-011-0076-2","article-title":"Pharmacogenetics in chronic heart failure: new developments and current challenges","volume":"9","author":"Talameh","year":"2012","journal-title":"Curr Heart Fail Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1161\/CIRCRESAHA.118.312706","article-title":"Established and emerging roles of biomarkers in heart failure","volume":"123","author":"Ibrahim","year":"2018","journal-title":"Circ Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"601364","DOI":"10.3389\/fcvm.2020.601364","article-title":"Biomarkers for heart failure prognosis: proteins, genetic scores and non-coding RNAs","volume":"7","author":"Shrivastava","year":"2020","journal-title":"Front Cardiovasc Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1093\/eurheartj\/ehs337","article-title":"Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies","volume":"34","author":"Pocock","year":"2013","journal-title":"Eur Heart J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"D521","DOI":"10.1093\/nar\/gkl923","article-title":"HMDB: the Human Metabolome Database","volume":"35","author":"Wishart","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/anie.201804736","article-title":"High-throughput metabolomics by 1D NMR","volume":"58","author":"Vignoli","year":"2019","journal-title":"Angew Chem-Int Edit."},{"key":"B11","doi-asserted-by":"publisher","first-page":"a000588","DOI":"10.1101\/mcs.a000588","article-title":"Metabolomics: an emerging but powerful tool for precision medicine","volume":"1","author":"Clish","year":"2015","journal-title":"Cold Spring Harb Mol Case Stud."},{"key":"B12","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3390\/cancers12020314","article-title":"Effect of estrogen receptor status on circulatory immune and metabolomics profiles of HER2-positive breast cancer patients enrolled for neoadjuvant targeted chemotherapy","volume":"12","author":"Vignoli","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nrd.2016.32","article-title":"Emerging applications of metabolomics in drug discovery and precision medicine","volume":"15","author":"Wishart","year":"2016","journal-title":"Nat Rev Drug Discov."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1053\/j.gastro.2014.01.058","article-title":"Diet and the Intestinal Microbiome: Associations, Functions, and Implications for Health and Disease","volume":"146","author":"Albenberg","year":"2014","journal-title":"Gastroenterology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1021\/acs.jproteome.9b00850","article-title":"Fingerprinting Alzheimer's disease by 1H nuclear magnetic resonance spectroscopy of cerebrospinal fluid","volume":"19","author":"Vignoli","year":"2020","journal-title":"J Proteome Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1097\/MCG.0000000000000236","article-title":"Application of NMR-based metabolomics to the study of gut microbiota in obesity","volume":"48","author":"Calvani","year":"2014","journal-title":"J Clin Gastroenterol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3109\/14767058.2013.823941","article-title":"Metabolomic profile of term infants of gestational diabetic mothers","volume":"27","author":"Dani","year":"2014","journal-title":"J Maternal Fetal Neonatal Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12916-018-1240-2","article-title":"NMR-based metabolomics identifies patients at high-risk of death within two years after acute myocardial infarction in the AMI-Florence II cohort","volume":"17","author":"Vignoli","year":"2019","journal-title":"BMC Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/nm1202-802","article-title":"Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics","volume":"8","author":"Brindle","year":"2002","journal-title":"Nat Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1161\/CIRCULATIONAHA.111.060368","article-title":"Metabolomic Profiling for identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function","volume":"126","author":"Shah","year":"2012","journal-title":"Circulation."},{"key":"B21","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1021\/acs.jproteome.9b00779","article-title":"Differential network analysis reveals metabolic determinants associated with mortality in acute myocardial infarction patients and suggests potential mechanisms underlying different clinical scores used to predict death","volume":"19","author":"Vignoli","year":"2020","journal-title":"J Proteome Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e0175591","DOI":"10.1371\/journal.pone.0175591","article-title":"Identification of a plasma metabolomic signature of thrombotic myocardial infarction that is distinct from non-thrombotic myocardial infarction and stable coronary artery disease","volume":"12","author":"DeFilippis","year":"2017","journal-title":"PLoS ONE."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1161\/CIRCRESAHA.117.311002","article-title":"Cardiovascular metabolomics","volume":"122","author":"McGarrah","year":"2018","journal-title":"Circ Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart\u2014an engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N Engl J Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1161\/CIRCULATIONAHA.107.702795","article-title":"Metabolic mechanisms in heart failure","volume":"116","author":"Ashrafian","year":"2007","journal-title":"Circulation."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jacc.2014.04.083","article-title":"Metabolic impairment in heart failure: the myocardial and systemic perspective","volume":"64","author":"Doehner","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s11897-016-0289-5","article-title":"Metabolic dysfunction in heart failure: diagnostic, prognostic, and pathophysiologic insights from metabolomic profiling","volume":"13","author":"Hunter","year":"2016","journal-title":"Curr Heart Fail Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"E113","DOI":"10.1016\/j.ijcard.2013.08.042","article-title":"Metabolomic fingerprint of heart failure in humans: A nuclear magnetic resonance spectroscopy analysis","volume":"168","author":"Tenori","year":"2013","journal-title":"Int J Cardiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12967-015-0661-3","article-title":"Metabolomic approach to profile functional and metabolic changes in heart failure","volume":"13","author":"Deidda","year":"2015","journal-title":"J Transl Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e88102","DOI":"10.1371\/journal.pone.0088102","article-title":"1H-NMR-based metabolic analysis of human serum reveals novel markers of myocardial energy expenditure in heart failure patients","volume":"9","author":"Du","year":"2014","journal-title":"PLoS ONE."},{"key":"B31","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jchf.2017.07.009","article-title":"Targeted metabolomic profiling of plasma and survival in heart failure patients","volume":"5","author":"Lanfear","year":"2017","journal-title":"JACC Heart Fail."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e60737","DOI":"10.1371\/journal.pone.0060737","article-title":"Metabonomics analysis of plasma reveals the lactate to cholesterol ratio as an independent prognostic factor of short-term mortality in acute heart failure","volume":"8","author":"Desmoulin","year":"2013","journal-title":"PLoS ONE."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.jacc.2015.02.018","article-title":"Metabolic disturbances identified in plasma are associated with outcomes in patients with heart failure: diagnostic and prognostic value of metabolomics","volume":"65","author":"Cheng","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","volume":"93","year":"1996","journal-title":"Circulation"},{"key":"B36","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10858-011-9489-1","article-title":"Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks","volume":"49","author":"Bernini","year":"2011","journal-title":"J Biomol NMR."},{"key":"B37","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/cmr.a.20223","article-title":"How the 1D-NOESY suppresses solvent signal in metabonomics NMR spectroscopy: an examination of the pulse sequence components and evolution","author":"Mckay","year":"2011","journal-title":"Concepts Magn Reson"},{"key":"B38","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1021\/ac051632c","article-title":"Schlotterbeck G+, Senn H. Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures application in 1H NMR metabonomics","volume":"78","author":"Dieterle","year":"2006","journal-title":"AnalChem."},{"key":"B39","first-page":"336","volume-title":"Metabolomics, Metabonomics and Metabolite Profiling","author":"Griffiths","year":"2008"},{"key":"B40","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/cem.785","article-title":"Partial least squares for discrimination","volume":"17","author":"Barker","year":"2003","journal-title":"J Chemom."},{"key":"B41","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4612-4380-9_37","article-title":"Regression models and life-tables","volume-title":"Breakthroughs in statistics: methodology and distribution","author":"Cox","year":"1992"},{"key":"B42","doi-asserted-by":"publisher","first-page":"11962","DOI":"10.1021\/acs.analchem.8b02412","article-title":"Quantitative lipoprotein subclass and low molecular weight metabolite analysis in human serum and plasma by 1H NMR spectroscopy in a multilaboratory trial","volume":"90","author":"Jim\u00e9nez","year":"2018","journal-title":"Anal Chem."},{"key":"B43","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J Royal Stat Soc Ser B (Methodological)."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-386983-8.00001-9","author":"Wilcox","year":"2012","journal-title":"Introduction to Robust Estimation and Hypothesis Testing"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1016\/j.jacc.2007.09.021","article-title":"Natriuretic peptides","volume":"50","author":"Daniels","year":"2007","journal-title":"J Am Coll Cardiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1056\/NEJMoa020233","article-title":"Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure","volume":"347","author":"Maisel","year":"2002","journal-title":"N Engl J Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.ahj.2009.06.018","article-title":"Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials","volume":"158","author":"Felker","year":"2009","journal-title":"Am Heart J."},{"key":"B49","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ahj.2014.07.008","article-title":"Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population","volume":"168","author":"Cheng","year":"2014","journal-title":"Am Heart J."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/ejhf.807","article-title":"Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study","volume":"19","author":"Tsuji","year":"2017","journal-title":"Eur J Heart Fail."},{"key":"B51","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.pcad.2005.02.001","article-title":"Neurohumoral pathways in heart failure with preserved systolic function","volume":"47","author":"Hogg","year":"2005","journal-title":"Prog Cardiovasc Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/cvr\/cvn301","article-title":"Energy metabolism in heart failure and remodelling","volume":"81","author":"Ingwall","year":"2009","journal-title":"Cardiovasc Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1152\/physrev.2000.80.3.1107","article-title":"Creatine and creatinine metabolism","volume":"80","author":"Wyss","year":"2000","journal-title":"Physiol Rev."},{"key":"B54","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12968-018-0491-6","article-title":"Cardiac work is related to creatine kinase energy supply in human heart failure: a cardiovascular magnetic resonance spectroscopy study","volume":"20","author":"Gabr","year":"2018","journal-title":"J Cardiovasc Magn Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1161\/CIRCRESAHA.113.300974","article-title":"Creatine\u2014a dispensable metabolite?","volume":"112","author":"Taegtmeyer","year":"2013","journal-title":"Circ Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1161\/CIRCULATIONAHA.105.572990","article-title":"Supranormal myocardial creatine and phosphocreatine concentrations lead to cardiac hypertrophy and heart failure","volume":"112","author":"Wallis","year":"2005","journal-title":"Circulation."},{"key":"B57","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1161\/01.RES.0000137170.41939.d9","article-title":"Is the failing heart energy starved?","volume":"95","author":"Ingwall Joanne","year":"2004","journal-title":"Circ Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1093\/ndt\/gfq066","article-title":"Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference","volume":"25","author":"Bagshaw","year":"2010","journal-title":"Nephrol Dial Transplant."},{"key":"B59","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nrneph.2016.113","article-title":"Heart failure and kidney dysfunction: epidemiology, mechanisms and management","volume":"12","author":"Schefold","year":"2016","journal-title":"Nature Reviews Nephrology."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1093\/eurheartj\/ehi389","article-title":"The importance of the gastrointestinal system in the pathogenesis of heart failure","volume":"26","author":"Krack","year":"2005","journal-title":"Eur Heart J."},{"key":"B61","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41569-018-0108-7","article-title":"Dietary metabolism, the gut microbiome, and heart failure","volume":"16","author":"Tang WHW Li","year":"2019","journal-title":"Nat Rev Cardiol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.healun.2009.04.026","article-title":"High-density lipoprotein cholesterol levels and prognosis in advanced heart failure","volume":"28","author":"Mehra","year":"2009","journal-title":"J Heart Lung Transpl."},{"key":"B63","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/eurheartj\/ehi195","article-title":"Prognostic significance of serum cholesterol levels in patients with idiopathic dilated cardiomyopathy","volume":"27","author":"Christ","year":"2006","journal-title":"Eur Heart J."},{"key":"B64","first-page":"521","article-title":"Low serum triglyceride levels as predictors of cardiac death in heart failure patients","volume":"40","author":"Kozdag","year":"2013","journal-title":"Tex Heart Inst J."},{"key":"B65","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cardfail.2007.01.007","article-title":"Association of low serum levels of apolipoprotein A-I with adverse outcomes in patients with nonischemic heart failure","volume":"13","author":"Iwaoka","year":"2007","journal-title":"J Card Fail."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s00216-016-0074-z","article-title":"NMR-based metabolomic approach to study urine samples of chronic inflammatory rheumatic disease patients","volume":"409","author":"Vignoli","year":"2017","journal-title":"Anal Bioanal Chem."},{"key":"B67","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1161\/CIRCHEARTFAILURE.113.000813","article-title":"Long-term functional and clinical follow-up of patients with heart failure with recovered left ventricular ejection fraction after \u03b2-blocker therapy","volume":"7","author":"de Groote","year":"2014","journal-title":"Circ Heart Fail."},{"key":"B68","doi-asserted-by":"publisher","first-page":"e011077","DOI":"10.1161\/JAHA.118.011077","article-title":"Characteristics, outcomes, and treatment of heart failure with improved ejection fraction","volume":"8","author":"Park","year":"2019","journal-title":"J Am Heart Assoc."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.851905\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T04:33:53Z","timestamp":1649306033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.851905\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,7]]},"references-count":68,"alternative-id":["10.3389\/fcvm.2022.851905"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.851905","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,7]]},"article-number":"851905"}}